Sector ratings Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 01:30:00 05/09/2026 am IST			5-day change	1st Jan Change
3.130 ^USD	+0.32%		+0.64%	+13.82%

19/08	BMO Capital Initiates Perspective Therapeutics at Outperform	MT
14/08	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
PERSPECTIVE THERAPEUTICS, INC.	36Cr	-	BBB	-	-
LONZA GROUP AG	4.89TCr		AAA
REVOLUTION MEDICINES, INC.	4.5TCr	-	B	-	-
IQVIA HOLDINGS INC.	4.41TCr		AAA
BEONE MEDICINES AG	4.07TCr		-
CELLTRION, INC.	3.35TCr		A
ASCENDIS PHARMA A/S	1.78TCr	-	-	-	-
MEDPACE HOLDINGS, INC.	1.65TCr		BBB
EUROFINS SCIENTIFIC SE	1.47TCr		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.38TCr		AA
ICON PUBLIC LIMITED COMPANY	1.27TCr		AAA
TEMPUS AI, INC.	1.17TCr		A		-
BIO-TECHNE CORPORATION	1.14TCr		AA
ABIVAX	977.71Cr	-	BBB	-	-
PHARMARON BEIJING CO., LTD.	1.04TCr		AA
PRAXIS PRECISION MEDICINES, INC.	982.25Cr	-	B	-	-
KYMERA THERAPEUTICS, INC.	976.11Cr	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	965.36Cr	-	A	-	-
PROTAGONIST THERAPEUTICS, INC.	942.93Cr		BB		-
QIAGEN N.V.	898.96Cr		AAA
Average	1.89TCr		A
Weighted average by Cap.			A

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!